Leonteq Securities AG’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Leonteq Securities AG’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,475	Closed	-$1.19M	–	1149
2021 Q1	$1.19M	Buy	5,475 +45	+0.8%	+$8.46K	0.07%	230
2020 Q4	$627K	Buy	+5,430	New	+$608K	0.03%	359

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Leonteq Securities AG's GWPH Position: Q2 2021 in Review

Leonteq Securities AG sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 5,475 shares — an estimated $1.19M sold.

Leonteq Securities AG first reported a position in GWPH in Q4 2020 and held it in 2 quarters. The position peaked at $1.19M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

Leonteq Securities AG reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
Leonteq Securities AG sold 5,475 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $1.19M.
Leonteq Securities AG first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2020 and held it in 2 quarters.
Leonteq Securities AG's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.19M in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Leonteq Securities AG's 13F filing for Q2 2021, filed 26 Mar 2026.